Cargando…

Fasting insulin levels correlate with the frequency of hypoglycemic events in people with type 2 diabetes on treatment with sulfonylureas: A pilot study

AIMS AND OBJECTIVES: We aimed to explore whether fasting insulin levels correlate with the risk of hypoglycemia in people with Type 2 diabetes (T2D) receiving sulfonylureas (SUs). MATERIALS AND METHODS: Our study included 58 individuals with T2D who had been on treatment with SUs, but not insulin, f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolokas, Konstantinos, Koufakis, Theocharis, Avramidis, Iakovos, Gerou, Spyridon, Chatzidimitriou, Maria, Kazakos, Kyriakos, Kotsa, Kalliopi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074423/ https://www.ncbi.nlm.nih.gov/pubmed/32201446 http://dx.doi.org/10.4103/ijp.IJP_80_19

Ejemplares similares

COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong
por: Koufakis, Theocharis, et al.
Publicado: (2022)

Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun
por: Karras, Spyridon N, et al.
Publicado: (2019)

Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individuals
por: Karras, Spyridon N., et al.
Publicado: (2023)

Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis
por: Koufakis, Theocharis, et al.
Publicado: (2022)

Deconvoluting the Biological Roles of Vitamin D-Binding Protein During Pregnancy: A Both Clinical and Theoretical Challenge
por: Karras, Spyridon N., et al.
Publicado: (2018)

How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma
por: Arvanitakis, Konstantinos, et al.
Publicado: (2022)

The Relationship between Primary Hyperparathyroidism and Thrombotic Events: Report of Three Cases and a Review of Potential Mechanisms
por: Koufakis, Theocharis, et al.
Publicado: (2018)

Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities
por: Ogrotis, Ioannis, et al.
Publicado: (2023)

Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus
por: Grigoriadis, Gregory, et al.
Publicado: (2023)

Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes
por: Kyriakidou, Artemis, et al.
Publicado: (2022)

Effects of Christian Orthodox Fasting Versus Time-Restricted Eating on Plasma Irisin Concentrations Among Overweight Metabolically Healthy Individuals
por: Karras, Spyridon N., et al.
Publicado: (2021)

The importance of sleep quality, quantity, and chronotype in the management of diabetes: Is it time to wake up?
por: Koufakis, Theocharis, et al.
Publicado: (2022)

Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle?
por: Koufakis, Theocharis, et al.
Publicado: (2022)

Managing Diabetes in the Era of Financial Crisis: Need to Look Beyond the Obvious
por: Koufakis, Theocharis, et al.
Publicado: (2018)

Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases
por: Koufakis, Theocharis, et al.
Publicado: (2021)

Looking deeper into the findings of DARE-19: Failure or an open door to future success?
por: Koufakis, Theocharis, et al.
Publicado: (2021)

The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives
por: Pegiou, Stavroula, et al.
Publicado: (2021)

Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care
por: Rentzeperi, Elpiniki, et al.
Publicado: (2022)

Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?
por: Koufakis, Theocharis, et al.
Publicado: (2021)

Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches
por: Vasdeki, Dimitra, et al.
Publicado: (2022)

Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis
por: Romley, John A, et al.
Publicado: (2015)

First Report of Diabetes Phenotype due to a Loss-of-Function ABCC8 Mutation Previously Known to Cause Congenital Hyperinsulinism
por: Koufakis, Theocharis, et al.
Publicado: (2019)

From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients
por: Koufakis, Theocharis, et al.
Publicado: (2022)

Discordant Timing of Hypoglycemic Agent Screening Causing Delayed Diagnosis of Sulfonylurea-Induced Hypoglycemia
por: Folick, Andrew, et al.
Publicado: (2022)

Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry
por: Souliotis, Kyriakos, et al.
Publicado: (2020)

Self-Reported Frequency and Impact of Hypoglycemic Events in Spain
por: Orozco-Beltrán, Domingo, et al.
Publicado: (2014)

Insulin use in chronic kidney disease and the risk of hypoglycemic events
por: Grube, Daulton, et al.
Publicado: (2022)

Management of isolated sternal fractures using a practical algorithm
por: Karangelis, Dimos, et al.
Publicado: (2014)

Frequency and Severity of Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with a Sulfonylurea-Based Regimen at University-Affiliated Hospitals in Korea: The Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects Study
por: Kim, Yon Su, et al.
Publicado: (2019)

Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes
por: Sreenan, Seamus, et al.
Publicado: (2014)

Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections
por: Riddlesworth, Tonya, et al.
Publicado: (2017)

Uncovering undetected hypoglycemic events
por: Unger, Jeff
Publicado: (2012)

Vitamin D Alleviates Anxiety and Depression in Elderly People with Prediabetes: A Randomized Controlled Study
por: Zaromytidou, Evangelia, et al.
Publicado: (2022)

Staphylococcal scalded skin syndrome in an adult, immunocompetent patient
por: Koufakis, Theocharis, et al.
Publicado: (2015)

Adult intussusception
por: Nalmpantidis, Georgios, et al.
Publicado: (2012)

A Systematic Review of Insulin Management Recommendations to Improve Glycemic Control and Reduce Hypoglycemic Events During Ramadan Fasting in Patients With Insulin-Requiring Type 2 Diabetes
por: Kieu, Alexander, et al.
Publicado: (2022)

Quetiapine-Induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone
por: Koufakis, Theocharis
Publicado: (2016)

Optical control of insulin release using a photoswitchable sulfonylurea
por: Broichhagen, Johannes, et al.
Publicado: (2014)

An uncommon cause of progressive visual loss in a heavy smoker
por: Koufakis, Dimitris, et al.
Publicado: (2015)

Vitamin D in Fibromyalgia: A Causative or Confounding Biological Interplay?
por: Karras, Spyridon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dt0bg9ufc8vikas1ersnn203qh